Invention Grant
- Patent Title: Agents, uses and methods for the treatment of synucleinopathy
-
Application No.: US15812648Application Date: 2017-11-14
-
Publication No.: US10889635B2Publication Date: 2021-01-12
- Inventor: Pekka Kallunki , Paul E. G. Kristjansen
- Applicant: H. Lundbeck A/S
- Applicant Address: DK Valby
- Assignee: H. Lundbeck A/S
- Current Assignee: H. Lundbeck A/S
- Current Assignee Address: DK Valby
- Agency: Wolf, Greenfield & Sacks, P.C.
- Priority: DK201600710 20161115
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/18 ; A61P25/28 ; A61P25/16 ; A61K45/06 ; A61K39/00
Abstract:
The invention relates to combinational treatment using a monoclonal anti-alpha-synuclein antibody and an additional medicament. The antibodies can be used for treating a synucleinopathy such as Parkinson's disease (including idiopathic and inherited forms of Parkinson's disease), Diffuse Lewy Body Disease (DLBD), Lewy body variant of Alzheimer's disease (LBV), Combined Alzheimer's and Parkinson disease, pure autonomic failure and multiple system atrophy together with another medicament of the invention.
Public/Granted literature
- US20180194833A1 AGENTS, USES AND METHODS FOR THE TREATMENT OF SYNUCLEINOPATHY Public/Granted day:2018-07-12
Information query
